Micro Emerging Active

Climb Bio's FDA Fast Track Designation

Neue Erzählung mit begrenzter Abdeckung – noch in der Entstehung.

Score
0,2
Dynamik
▲ 0,0
Artikel
3
Quellen
1

Sentiment-Zeitachse

Ereignis-Zeitachse

Mai 05, 2026
Climb Bio (CLYM) Enters Agreement for $110M Private Placement Financing Bullish
Apr 24, 2026
Arbutus Biopharma (ABUS) Wins FDA Fast Track for Imdusiran Bullish
Apr 22, 2026
FDA Fast Track and a BTIG Buy; Is Climb Bio (CLYM) a … Neutral

Verwandte Artikel

Climb Bio (CLYM) Enters Agreement for $110M Private Placement Financing

Yahoo Finance · Mai 05, 2026
Bearish

Arbutus Biopharma (ABUS) Wins FDA Fast Track for Imdusiran

Yahoo Finance · Apr 24, 2026
Mixed

Zeitverlauf

Zuletzt aktualisiertApr 22, 2026